The Livzon Intellectual Property Department (IPD) was established in 2010. It is integral to maintaining the Livzon Pharmaceutical Group’s core competitiveness.
As of July 31, 2018 the Livzon Pharmaceutical Group and its subsidiary enterprises hold a total of 458 patents, including 321 licensed patents. Among the patents there are 255 national invention patents (175 licensed), 59 utility model patents (40 licensed), 77 design patents (75 licensed), 9 through PCT application, and 67 foreign invention patents (31 foreign patent licensing).
The Livzon Pharmaceutical Group has won the 13th, 15th, and 19th China Patent Award of Excellence, and has also won the Guangdong Patent Gold Award and the Excellence Award and the Zhuhai Patent Gold Award a number of times. In addition, Livzon Pharmaceutical Group is honored as National Intellectual Property Demonstration Enterprise, Examiner Practice Unit of the Medical Inventions Review Department of State Patent Office and Examiner Practice Unit of the Medical Inventions Review Department of Guangdong Patent Review Collaboration Center. Furthermore, the Intellectual Property Management division of the Livzon Pharmaceutical Group has passed the GB/T 29490-2013 certification.